Successful Treatment of Kodamaea ohmeri Bloodstream Infection with Voriconazole: A Case Report and Literature Review

<i>Kodamaea ohmeri</i> is an emerging opportunistic yeast pathogen frequently misidentified as <i>Candida</i>, posing significant diagnostic challenges. This report describes a case of <i>K. ohmeri</i> bloodstream infection in a 70-year-old female with poorly controlled diabetes following radical gastrectomy. Despite broad-spectrum antibacterial therapy for postoperative complications, she developed persistent fever. Blood cultures identified <i>K. ohmeri</i>, and antifungal susceptibility testing (AST) revealed a low voriconazole minimum inhibitory concentration (0.06 μg/mL), prompting targeted therapy that led to the clearance of fungemia and full clinical recovery. This case underscores the critical importance of rapid pathogen identification and AST-directed therapy in managing life-threatening <i>K. ohmeri</i> infections.

Authors

Institutions

Publication Details

Journal
Infection and Drug Resistance
Published
2025-12-01
DOI
https://doi.org/10.2147/idr.s564291
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful Treatment of Kodamaea ohmeri Bloodstream Infection with Voriconazole: A Case Report and Literature Review

Shengnan Pan, Chaogui Tang, Ning Lin, Lijun Yao et al.
Infection and Drug Resistance
Antifungal resistance and susceptibility
article

Successful Treatment of Kodamaea ohmeri Bloodstream Infection with Voriconazole: A Case Report and Literature Review

Shengnan Pan, Chaogui Tang, Ning Lin, Lijun Yao, Lijing Guo, K. T. Li, L. Lan, Weiren Zhu, Weichen Huang, Xuemin Jin, Chang Li, Qianhui Li, Jingjing Huang, Shuxin Sun, Qibing Xiong
article en

Abstract

<i>Kodamaea ohmeri</i> is an emerging opportunistic yeast pathogen frequently misidentified as <i>Candida</i>, posing significant diagnostic challenges. This report describes a case of <i>K. ohmeri</i> bloodstream infection in a 70-year-old female with poorly controlled diabetes following radical gastrectomy. Despite broad-spectrum antibacterial therapy for postoperative complications, she developed persistent fever. Blood cultures identified <i>K. ohmeri</i>, and antifungal susceptibility testing (AST) revealed a low voriconazole minimum inhibitory concentration (0.06 μg/mL), prompting targeted therapy that led to the clearance of fungemia and full clinical recovery. This case underscores the critical importance of rapid pathogen identification and AST-directed therapy in managing life-threatening <i>K. ohmeri</i> infections.

Infection and Drug ResistanceVol. Volume 18
Xuzhou Medical College (CN), Second People’s Hospital of Huai’an (CN), Nanjing Medical University (CN)
Nanjing Medical University
Openalex Percentile: Top 53%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.